Interim results from a phase II study of CC-486 in previously treated patients (pts) with locally advanced/metastatic nasopharyngeal cancer (NPC)

Category Primary study
JournalJournal of Clinical Oncology
Year 2016
This article has no abstract
Epistemonikos ID: 28b32ff7d7fbb0e5ae6421c17a210f3c07e5f275
First added on: Feb 07, 2025